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ENHANCEMENT OF BIO-PROTECTIVE FUNCTIONS BY LOW DOSE/DOSE-
RATE RADIATION
Kazuo Sakai  Research Center for Radiation Protection, National Institute of
Radiological Sciences 
Takaharu Nomura, Yasuhiro Ina  Low Dose Radiation Research Center, Central
Research Institute of Electric Power Industry 
 Effects of low-dose-rate gamma-irradiation on the process of tumorigenesis were inves-
tigated in mice treated with a carcinogenic agent or irradiated with high dose X-rays at a
high dose rate. A prolonged gamma irradiation at approximately 1 mGy/hr suppressed
the appearance of skin tumors induced by methylcholanthrene and delayed the appear-
ance of radiation-induced thymic lymphomas in C57BL/6 mice. We also investigated the
effects of low-dose-rate irradiation on disease model mice. In Type II diabetic C57BL/KsJ-
db/db (db) mice, the urine glucose level was improved in some of the mice irradiated at
0.70 mGy/hr, but not in non-irradiated control mice. In MRL-lpr/lpr (lpr) mice with
severe autoimmune diseases, immunological status was kept better in the mice irradiated
at 0.35 or 1.2 mGy/hr. The incidence of a number of symptoms, including lym-
phadenopathy, splenomegaly and proteinuria, was suppressed by the irradiation.
Furthermore, in both of the strains, the low-dose-rate irradiation prolonged the life span
of the irradiated mice. 
I. INTRODUCTION 
Low doses of ionizing radiation stimulate various biological functions:
anti-oxidative capacity1, DNA repair capability2, apoptosis3, 4, and immune
functions5, 6. Each of these functions may work in a suppressive manner
in the process of carcinogenesis, which would be initiated with DNA dam-
age induced directly by radiation or through reactive oxygen species pro-
duction. We have previously demonstrated that a low-dose-rate irradiation
at around 1 mGy/hr suppressed the incidence of methylcholanthrene-
induced skin tumors in ICR mice7. We also found some of biological pro-
tective functions, including anti-oxidative capacity and immune func-
tions, were enhanced. To examine the possibility that the augmented pro-
tective capacity may have some other effects in addition to the tumor sup-
pression, we investigated the effects of low dose irradiation on disease
model mice. 
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II. IRRADIATION FACILITIES 
Irradiation with low-dose-rate gamma rays was carried out in a clean
irradiation room (Figure 1) equipped with a 137Cs gamma-ray source (370
GBq). The dose rates at 5, 7 and 10 m from the source were 1.2, 0.70 and
0.35 mGy/hr, respectively. The irradiation was continued, except for 1 hr
intermissions in the morning on weekdays for care and examination of
the mice. The design of the irradiation facility and the details of dosime-
try with the ionization chamber and glass dosimeter have been described
elsewhere8. 
III. EFFECTS OF LOW DOSE/DOSE-RATE IRRADIATION ON THE
PROCESS OF TUMORIGENESIS
Chemically Induced Skin Tumors
Groups of thirty-five 5-week old female C57BL/6N mice were irradi-
ated with 137Cs gamma rays at a dose rate of 0.35, 0.70 or 1.2 mGy/hr for
5 weeks. Then, to induce skin tumors, the mice were subcutaneously
injected in the groin with 20-methylcholanthrene (MC), which had been
dissolved in olive oil, with each mouse receiving 0.1 ml9. The dose of MC
was 0.05 mg/mouse. After the MC injection, irradiation was continued at
the same dose rate. All animals were given food and water ad libitum fol-
lowing the guidelines for animal experiments at CRIEPI.
The first tumor appeared 53 days after the MC injection in non-irra-
diated control group. In the 0.35 mGy/hr group, the first tumors
appeared 75 days after the MC injection. In the 0.70 mGy/hr group, it
appeared 115 days after the injection. And in the 1.2 mGy/hr group, it
appeared 108 days after the injection. Cumulative tumor incidences, 200
days after the MC injection, are shown in Figure 2.
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FIGURE 1. Long-term low-dose-rate irradiation facility
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Radiation-Induced Thymic Lymphomas 
Thymic lymphomas were induced in female C57BL/6N mice by four
weekly X-irradiations of 1.8 Gy each. A group of 20 female mice, 5 weeks
old, were exposed to a low dose rate of 1.2 mGy/hr for 5 weeks, and then
they were subjected to the repeated high dose irradiation at a high dose
rate. Another group received only the fractionated high dose irradia-
tions. The first mouse death of thymic lymphoma occurred 89 days after
the last irradiation in the group that received only the repeated high dose
irradiations, while 110 days elapsed before the first death in the group
that received the repeated irradiations combined with the low-dose-rate
irradiation. The low-dose-rate irradiation appears to have delayed the
timing of the appearance of the lymphomas (Table 1). 
IV. EFFECTS OF LOW-DOSE-RATE IRRADIATION ON DISEASE MODEL
MICE 
Type II Diabetes 
A group of 12 female 10-week old C57BL/KsJ-db/db model mice with
Type II diabetes mellitus10 were irradiated for life at 0.70 mGy/hr. The
urine glucose levels of all of the mice were strongly positive at the begin-
ning of the irradiation. In the irradiated group, a decrease in the glucose
level was observed in three mice, one in the 35th week, another in the 52nd
week and the third in the 80th week. No recovery from the diabetes was
observed in the 12 mice of non-irradiated control group. 
There was no systematic change of body weight or consumption of
food and drinking water between the irradiated group and the non-irra-
diated group or between the recovered mice and the non-recovered
mice. 
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FIGURE 2. Cumulative tumor incidence in MC-injected mice irradiated at different dose rates. The
dotted line is the cumulative tumor incidence in the non-irradiated control group. 
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As shown in Table 2, survival was better in the irradiated group. A
marked difference was also observed in the appearance of the coat hair,
skin and tail. The irradiated group was in much better condition. 
Mortality was delayed and the healthy appearance was prolonged in
the irradiated mice by about 20-30 weeks compared with the control
mice. These results suggest that the low dose irradiation modified the
condition of the diabetic mice, leading not only to recovery from dia-
betes, but also to suppression of the aging process. 
Severe Autoimmune Disease 
MRL-lpr/lpr mice11 have a deletion of an apoptosis-regulating gene,
Fas, that causes abnormal proliferation activity of lymphocytes, leading to
severe total-body lymphadenopathy, splenomegaly and many autoim-
mune diseases. Groups of 12 female MRL-lpr/lpr mice, 7 weeks old, were
irradiated with 137Cs gamma rays at 0.35 or 1.2 mGy/hr for 5 weeks. Then,
they were kept in an animal care room without further irradiation. Table
3 summarizes the effects of low-dose-rate irradiation on the survival of the
mice. The life span of MRL-lpr/lpr mice was markedly prolonged in a
dose-rate dependent manner. Some of the symptoms typical in the mice
with autoimmune diseases, including lymphadenopathy and proteinuria,
were also suppressed12.
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TABLE 1. Effects of low dose irradiation on the appearance of radiation-induced thymic
lymphomas
THYMIC LYMPHOMAS (%)
Days after 1.8 Gy Repeated high dose Low-dose-rate irradiation before 






TABLE 2. Effects of Low-Dose-Rate Irradiation on Survival of C57BL/KsJ-db/db Mice 
SURVIVAL (%)
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A cytofluorographic analysis revealed the improvement of the
immunological status in the irradiated mice as the decrease in CD3+
B220+ cells, which attack their own organs and tissues, the decrease in
B220+ CD40+ cells, a representative cell population in autoimmune dis-
eases, and the increase in CD8+ T cells, which play important roles in
immune activity (Table 4). 
V. DISCUSSION
In the present study, suppression of tumorigenic processes was
demonstrated (Figure 2, Table I). We have observed some increase in
immune functions and tumor cell rejection capability in mice irradiated
with 1.2 mGy/hr for several weeks (manuscript in preparation).
Therefore, the enhancement of immune functions is presumably
involved in the tumor suppression, although the contribution of other
protective functions is not excluded. The significant involvement of
immune functions was also demonstrated in MRL-lpr/lpr mice (Table IV).
The life span prolongation seen in the diabetic mice may not be
directly correlated with the cure of diabetes, because the longer life span
was seen not only in those mice showing recovery, but also in non-recov-
ered mice. The low-dose-rate irradiation might have affected the process
of aging. In the process of ageing, oxidative stress are believed to be
involved.13 The increase in the antioxidative capacity in irradiated mice1,
14 might explain the anti-ageing effect of low-dose-rate irradiation. 
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TABLE 3. Effects of low-dose-rate irradiation on survival of MRL-lpr/lpr mice
SURVIVAL (%)
Age (days) 0 (mGy/hr) 0.35 (mGy/hr) 1.2 (mGy/hr)
100 100 100 100
125 67 100 100
150 0 83 100
175 0 25 100
200 0 17 83
TABLE 4. Effects of low-dose-rate irradiation on immune cell populations in MRL-lpr/lpr mice 
FRACTION OF CELL POPULATION (%) 
Cell Population 0 (mGy/hr) 0.35(mGy/hr) 1.2(mGy/hr)
CD3+B220+ 42 36 24
B220+CD40+ 13 10 7.6
CD8+ 3.1 5.6 5.8
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Although their mechanisms are to be elucidated, the phenomena
described in the present report should have a significant impact, on one
hand, on the basic assumption in the radiological protection, which
claims that radiation is harmful no matter how low the dose is. On the
other hand, they would be a trigger to explore the possibility of clinical
application of low dose/dose rate radiation. 
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